)
Epigral targets ₹5,000 crore revenue by FY31 on capacity expansions
- Epigral expects revenue of ₹2,900 crore this fiscal year
- Its FY31 target is ₹5,000 crore, driven by CPVC Resin and ECH scale-ups
- Capacity expansion and revenue targets put Epigral investors in focus; execution will determine growth